In a report released today, Matthew Biegler from Oppenheimer reiterated a Buy rating on Gilead Sciences (GILD – Research Report), with a price ...

Oppenheimer analyst Brian Schwartz increased the price target on Freshworks Inc (NASDAQ:FRSH) to $24 from $22, while retaining an Outperform rating on the shares. According to InvestingPro data, ...

Oppenheimer analyst Christopher Glynn maintained a Perform rating for Generac Holdings (NYSE:GNRC) following the company's fourth-quarter earnings report. According to InvestingPro data, Generac is ...

(JTA) — Friday is not just “Barbie” release day — moviegoers are also planning to fill theaters across the United States to see Christopher Nolan’s “Oppenheimer” biopic. Many hope it ...

Oppenheimer analyst Kenneth Wong maintained a Buy rating on Shopify (SHOP – Research Report) today and set a price target of $150.00. The ...

Pliant Therapeutics (NASDAQ:PLRX – Get Free Report)‘s stock had its “market perform” rating restated by analysts at Oppenheimer in a research note issued to investors on Monday, MarketBeat.com reports ...

Cillian Murphy’s dedication to Oppenheimer went beyond acting—he learned 30,000 words of Dutch, followed a brutal diet, and ...

Regal Rexnord (NYSE:RRX – Free Report) had its price objective reduced by Oppenheimer from $210.00 to $190.00 in a research note issued to investors on Friday,Benzinga reports. Oppenheimer currently ...

Benny Safdie is the latest actor to join the cast of The Odyssey, the next movie from Christopher Nolan, according to The ...

Oppenheimer downgraded Apple from "outperform" to "perform" because it is struggling to adapt to a competitive AI landscape.

Director Christopher Nolan is set to reunite with one of the stars from his multi-award-winning film Oppenheimer for his next ...

Investing.com -- Oppenheimer analysts warned that Tesla (NASDAQ: TSLA) faces rising risks as competition in both electric and ...